(Q37971860)

26 August 2017

Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors (English)

1 reference

26 August 2017

Lokesh Nagaprashantha

1

1 reference

26 August 2017

Neha Vartak

2

1 reference

26 August 2017

Sangeeta Awasthi

3

1 reference

26 August 2017

Sanjay Awasthi

4

1 reference

26 August 2017

Sharad S Singhal

5

1 reference

26 August 2017

28 December 2011

1 reference

26 August 2017

Pharmaceutical Research

1 reference

26 August 2017

29

1 reference

26 August 2017

3

1 reference

26 August 2017

621-636

1 reference

26 August 2017

Integrins and anoikis

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Cell adhesion in vascular biology. New insights into integrin-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Mechanisms of focal adhesion kinase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Multi-target therapeutics: when the whole is greater than the sum of the parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Small molecule integrin antagonists in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

An alpha5beta1 integrin inhibitor attenuates glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The integrin-linked kinase (ILK) suppresses anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The glucose-regulated proteins: stress induction and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

ER stress, hypoxia tolerance and tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Stress induction of GRP78/BiP and its role in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Glucose regulated proteins in cancer progression, drug resistance and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

STAT3 as a downstream mediator of Trk signaling and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Retracted: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

RalBP1 is necessary for metastasis of human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Recent insights into the structure and mechanism of the sodium pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

beta(1) integrin binds the 16-kDa subunit of vacuolar H(+)-ATPase at a site important for human papillomavirus E5 and platelet-derived growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Mevalonate pathway: a review of clinical and therapeutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Anticancer effects of zoledronic acid against human osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Personalized cancer diagnostics and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

"...those left behind." Biology and oncology of invasive glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Getting started in biological pathway construction and analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0645-9

Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression

21 January 2018

1 reference

12 December 2020

Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions

1 reference

12 December 2020

Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.

1 reference

12 December 2020

[Expression and significance of tyrosine kinase receptors B in nasopharyngeal carcinoma patients]

1 reference

12 December 2020

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

1 reference

12 December 2020

Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin

1 reference

12 December 2020

Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.

1 reference

12 December 2020

Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer

1 reference

12 December 2020

Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer

1 reference

12 December 2020

Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders

1 reference

12 December 2020

Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer

1 reference

12 December 2020

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

1 reference

12 December 2020

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

1 reference

12 December 2020

Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice

1 reference

12 December 2020

Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

1 reference

12 December 2020

The relationship between PTEN expression and anoikis in human lung carcinoma cell lines

1 reference

12 December 2020

K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.

1 reference

12 December 2020

Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells

1 reference

12 December 2020

Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma

1 reference

12 December 2020

Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family

1 reference

12 December 2020

SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor recepto

1 reference

12 December 2020

Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates

1 reference

12 December 2020

Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells

1 reference

12 December 2020

10.1007/S11095-011-0645-9

Identifiers

DOI

1 reference

release_yaak2ze44rhqrccelliqwdtx6a

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yaak2ze44rhqrccelliqwdtx6a

24 November 2022

mapped directly with Wikidata item

1 reference